Skip to main content
Screener/Healthcare/Biotechnology

AGIO — Agios Pharmaceuticals, Inc.

NASDAQ
$30.38-6.85 (-18.40%)
Mid CapUnder $50HealthcareFastest GrowingLow Beta
$22.24
$46.00
$29.80
$33.00
EPS (TTM)$-7.25
P/E Ratio-3.51
Dividend Yield—
Market Cap$2.21B
Volume2.33M
Prev Close$37.23
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$20.7M-$99.1M$-1.6993.6%-477.7%
Q4 '25$20.0M-$108.0M$-1.8596.9%-541.1%
Q3 '25$12.9M-$103.4M$-1.7887.0%-803.1%
Q2 '25$12.5M-$112.0M$-1.9376.2%-899.4%
Q1 '25$8.7M-$89.3M$-1.5587.6%-1023.3%
Q4 '24$10.7M-$96.5M$-1.6988.3%-899.6%
Q3 '24$9.0M$947.9M$16.2291.3%10574.7%
Q2 '24$8.6M-$96.1M$-1.6964.2%-1115.7%
Get Your Daily Market Recap